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1. Introduction 
Asteraceae is the largest family of the plant kingdom, very abundant and also a diverse one. 
The Asteraceae plants are the most widely distributed of all the families  (Porter, C.L. (1969); 
Evans W. (1989); Hutchinson, J.(1973); Core, E. L. (1955) of the angiosperms. It includes 
about 1400 genera and over 25000 species (Harborne , J. B., Turner, B.L. (1984); Aboul Ela, 
M. A.,(1991), forming approximately 10% of the flowering plants. 
Asteraceae has characteristic taxonomical characters (Muschler, R. (1912). Members of the 
family are generally herbs of annul or perennial habits and some tropical forms occur as 
shrubs. Flowers are grouped in heads known as capitula, surrounded by involucres.  It is of 
two kinds of florets; tubular or disc florets with tubular corolla and mostly hermaphrodite, 
and ligulate or ray floret, with starp like corolla and mostly female. 
2. Chemistry of genus Matricaria 
Genus Matricaria comprises plants with various secondary metabolites of different chemical 
nature recorded mainly in Matricaria chamomilla.German chamomile flowers contain 0.24- to 
2% volatile oil which is blue in color. Chamomile also contains up to 8% flavone glycosides 
and flavonol; up to 10 percent mucilage polysaccharides; up to 0.3 percent choline; and 
approximately 0.1 percent coumarines. The tannin level in chamomile is less than one 
percent. (Alternative Medicine Review (2008)) 
Following is a review of the chemical compounds that have been isolated previously from 
genus Matricaria (Tables 1, 2, 3, and 4). 
2.1 Volatile oil 
Name Source Structure References 
a) Azulene derivatives 
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Chamazulene M. chamomilla 
Alternative Medicine 
Review 2008, 
Ness, A.,Metzger, J. W., 
Shmidt, P. C. (1996) 
Chamazulene 
Carboxylic acid 
M. chamomilla 
HOOC
Stahl, E. (1954) 
Chamavioline M. chamomilla 
O
H
Motl, O. ,Repcak, M. 
(1979), 
Motl, O. ,Repcak, M. 
,Ubik, K. (1983) 
Matricin 
(proazulene) 
Ligulate and 
tubular floret 
only of M. 
chamomilla 
H3C
O
O
OCOCH3
HO
Alternative Medicine 
Review (2008), 
S˘orm, F.,Nowak, J., 
Herout, V.(1953), 
Cekan, Z., Herout, V., 
Sorm, F.,(1957) 
Matricarin M. chamomilla 
H3C
O
O
OCOCH3 Alternative Medicine 
Review (2008) 
b) Sesquiterpenes 
i) Oxygenated sesquiterpenes 
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HO
OH
OR1
OR3
OR21
2
3
4
5
6
7
8
9
10
11
(1R*,2R*,3R*,6R*,7R*)1,2
,3,6,7-pentahydroxy-
bisabolol-10(11)-ene 
M. aurea 
R1 R2 R3 Ahmed A. Ahmed, 
Maha A. Abou Elela 
(1999) H H H 
(1R*,2R*,3R*,6R*,7R*)1,2
,3,6,7-tetrahydroxy-1-
acetoxy-bisabolol-
10(11)-ene 
M. aurea Ac H H 
Ahmed A. Ahmed, et 
al.(1993) 
(1R*,2R*,3R*,6R*,7R*)1,2
,3,6,7-tetrahydroxy-2-
acetoxy-bisabolol-
10(11)-ene 
M. aurea H Ac H 
Ahmed A. Ahmed, 
Maha A. Abou Elela 
(1999) 
HO
OH
OR
1
2
3
4
5
6
7
8
9
10
11
(1R*,6R*,7R*)1,6,7-
trihydroxy-bisabolol-
2,10- diene 
M. aurea 
R 
Ahmed A. Ahmed, et 
al.(1993) H 
(1R*,6R*,7R*)1,6,7-
trihydroxy-1-
acetoxybisabolol-2,10-
diene 
M. aurea Ac 
Ahmed A. Ahmed, et 
al.(1993) 
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(-)--bisabolol M. chamomilla 
OH
Alternative Medicine 
Review (2008), 
S˘orm, F.,Zaoral 
M.,Herout, V.(1951) 
(-)--bisabolol  oxide  A M. chamomilla O
OH
Alternative Medicine 
Review 2008, 
Sampath , V., et al (1969) 
(-)--bisabolol  oxide  B M. chamomilla O
OH
Alternative Medicine 
Review (2008), 
Sampath ,V.,Sabata, et al 
,(1969) 
(-)--bisabolol oxide C M. chamomilla O
OH
Schilcher, H., et al (1976) 
-bisabolone  oxide 
M. chamomilla 
growing in 
turkey 
O
O
Hölzl, J., Demuth, 
G.(1973) 
www.intechopen.com
 
General Introduction on Family Asteracea 
 
379 
Spathulenol M. chamomilla 
HO
Alternative Medicine 
Review (2008), 
Motl, O., et al(1977) 
Caryophyllene  epoxide M. chamomilla 
O
Reichling, J., et al (1983) 
ii) Unsaturated sesquiterpenes 
┚-bisabolene M. chamomilla 
Anne  ORAV, Tiiu 
KAILAS, and Kaire 
IVASK (2001) 
 
 
Trans-- farnesene M. chamomilla 
Alternative Medicine 
Review (2008), 
Lemberovics, E. (1979) 
Trans --farnesene M. chamomilla Lemberovics, E. (1979) 
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┚-selinene M. chamomilla A.Pizard, et al.(2006) 
Germacrene D M. chamomilla 
Anne  ORAV, Tiiu 
KAILAS, and Kaire 
IVASK (2001) 
A.Pizard, et al.(2006) 
Germacrene A M. chamomilla A.Pizard, et al.(2006) 
Bicyclo germacrene M. chamomilla A.Pizard, et al.(2006) 
Cadinene M. chamomilla 
Alternative Medicine 
Review (2008), 
Anne  ORAV, Tiiu 
KAILAS, and Kaire 
IVASK (2001) 
 
-muurolene, M. chamomilla Motl, O., Repcak, 
M.(1979) 
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Calamemene M. chamomilla 
 
 
Motl, O., Repcak, 
M.(1979) 
┚-caryophyllene 
In the root oil 
of M. 
chamomilla 
 
 
Reichling, J., et al (1983) 
c) Monoterpenes 
┙-pinene M. chamomilla 
 
 
Anne  ORAV, Tiiu 
KAILAS, and Kaire 
IVASK (2001),  
A.Pizard, et al.(2006) 
┙-Terpinene M. chamomilla 
 
 
 
A.Pizard, et al.(2006) 
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Myrcene M. chamomilla 
Stransky, K., et al., 
(1981) 
Sabinene M. chamomilla 
Anne  ORAV, Tiiu 
KAILAS, and Kaire 
IVASK (2001) 
, A. Pizard, et al.(2006) 
Gerianol M. chamomilla 
CH2OH
Stransky, K., et al., 
(1981) 
Spiroethers 
Cis (Z)-enyne 
dicycloether 
cis-2-[hexadiyne)- (2,4)-
ylidene]-1,6-dioxaspiro-
[4,4]-nonene) 
M. chamomilla 
O
O
H Alternative Medicine 
Review (2008), 
Bohlmann, F., Zdero, C. 
(1982), 
Bohlmann, F., et al 
,(1961) 
www.intechopen.com
 
General Introduction on Family Asteracea 
 
383 
Trans (E)-enyne 
dicycloether 
trans-2-[hexadiyne)- 
(2,4)-ylidene]-1,6-
dioxaspiro-[4,4]-nonene
M. chamomilla O
O
H
Alternative Medicine 
Review (2008), 
Bohlmann, F., et al 
,(1961), 
Bohlmann, F., Zdero, C. 
(1982) 
(3S*,4S*,5R*)-(E)-3,4-
dihydroxy-2-(hexa-2,4-
diynyliden)-1,6-
dioxaspiro-(4,5) decane
M. aurea 
O
OHHO
Ahmed A. Ahmed, 
Maha A. Abou Elela 
(1999) 
Table 1. Volatile components isolated from Matricaria species 
2.2 Flavonoids 
a) Flavone aglycon and glycosides isolated  from species Chamomilla 
O
O
R3'
R4'
R5
R7
R6
1
2
34
5
6
7
8
1'
2'
3'
4'
5'
6'
Name Source R5 R6 R7 R3’ R4’ Ref. 
i) Flavone aglycon 
Apigenin 
Ligulate 
florets 
flowers 
OH  OH  OH 
Powe, F., Browning, H. Jr. 
(1914), 
S˘orm, P.,et al.,(1952), 
Kunde, R., Isaac, O.(1979), 
Carle, R. and Isaac, O. (1985) 
Luteolin flowers OH  OH OH OH 
Kunde, R., Isaac, O.(1979), 
Carle, R. and Isaac, O. (1985) 
Chrysoseriol flowers OH  OH OCH3 OH 
Carle, R. and Isaac, O. (1985) , 
Reichling, J., et al., (1979) 
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ii) Flavone glycosides 
Luteolin-7-
glucoside 
Egyptian 
chamomile 
floret 
(leaves) 
Ligulate 
florets 
OH  OGlu OH OH 
Kunde, R., Isaac, O.(1979), 
Elkiey, M. A.,et al., (1963), 
Greger, H. (1975) 
Luteolin-4’-
glucoside 
 OH  OH OH OGlu  
Chrysoseriol-
7-glucoside 
Leaves OH  OGlu OCH3 OH Greger, H. (1975) 
Apigenin-7-
glucoside 
(Apigetrin) 
Ligulate 
floret 
OH  OGlu  OH 
Kunde, R., Isaac, O.(1979), 
Lang, W., Schwandt, K. (1957), 
Hörhammer, L., Wagner, H., 
Salfner, B. (1963) 
Apigenin-7-
(6’’-O-
acetyl)-
glucoside 
Ligulate 
florets 
OH  
OGlu-
ac. 
 OH 
Kunde, R., Isaac, O.(1979), 
Redaelli, C., Formentini, L., 
Santaniello, E. (1979) 
Apigenin-7-
(6’’-O-
apiosyl)-
glucoside 
(apiin) 
Ligulate 
florets 
OH  
OGlu-
Apio.
 OH 
Kunde, R., Isaac, O.(1979), 
Wagner, H., Kirmayer, W. 
(1957) 
b) Flavonol aglycones and glycosides isolated  from  Chamomilla species 
O
O
R3'
R4'
R5
R7
R6
1
2
3
4
5
6
7
8
1'
2'
3'
4'
5'
6'
R3
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Name Source R3 R5 R6 R7 R3’ R4’ Ref. 
i) Flavonol aglycones 
Lutuletin 
Tubular 
floret 
flowes 
OH OH OCH3 OH OH OH 
Kunde, R., Isaac, 
O.(1979), 
Carle, R. and Isaac, O. 
(1985) , 
Ahmed A. Ahmed, 
Maha A. Abou Elela 
(1999) 
Quercetin 
Leaves 
Tubular 
floret 
flowers 
OH OH  OH OH OH 
Kunde, R., Isaac, 
O.(1979), 
Carle, R. and Isaac, O. 
(1985), 
Greger, H. (1975) 
Chrysosplenol 
Chamomile 
flower 
OCH3 OH OCH3 OCH3 OH OH 
Carle, R. and Isaac, O. 
(1985), 
Exner, J., et al., (1981), 
Hänsel, R., Rimpler, H., 
Walther, K. (1966) 
Chrysosplenit
in 
Flowers OCH3 OH OCH3 OCH3 OCH3 OH 
Carle, R. and Isaac, O. 
(1985) , 
Hänsel, R., Rimpler, H., 
Walther, K. (1966) 
Eupatoletin 
Chamomile 
flower 
Ligulate 
florets 
OH OH OCH3 OCH3 OH OH 
Kunde, R., Isaac, 
O.(1979), 
Carle, R. and Isaac, O. 
(1985), 
Exner, J., et al., (1981), 
Hänsel, R., Rimpler, H., 
Walther, K. (1966) 
Eupalitin 
Chamomile 
flower 
OH OH OCH3 OCH3  OH 
Carle, R. and Isaac, O. 
(1985), 
Exner, J., et al., (1981), 
Hänsel, R., Rimpler, H., 
Walther, K. (1966) 
ii) Flavonol glycosides 
Quercetin-7-
glucoside 
(Quercimeritri
n) 
Tubular 
floret 
OH OH  OGlu OH OH 
Kunde, R., Isaac, 
O.(1979), 
Lang, W., Schwandt, K. 
(1957) 
, Horhammer, L., 
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Wagner, H., Salfner, B. 
(1963) 
Quercetin-3-
rutinoside 
Chamomil
e flower 
OGlu-
Rham
OH  OH OH OH 
Elkiey, M. A.,et al., 
(1963) 
Quercetin-3-
galactoside 
Chamomil
e flower 
OGal OH  OH OH OH 
Elkiey, M. A.,et al., 
(1963) 
Table 2. Flavone and flavonol aglycon and glycosides isolated from species Chamomilla 
2.3 Coumarines and other polyphenolic compounds 
a) Coumarines 
O OR1O
R2
1
2
3
45
6
7
8
Name Source R1 R2 Ref. 
Herniarin 
Ligulate and Tubular floret 
of M. chamomilla 
CH3 H Schilcher, H. (1985) 
Umbelliferone 
Ligulate and Tubular floret 
of M. chamomilla 
H H Schilcher, H. (1985) 
Isoscopoletin M. chamomilla CH3 H Kotov, A. G., et al., (1991) 
Esculetin M. chamomilla H OH Kotov, A. G., et al., (1991) 
Scopoletin M. chamomilla H OCH3 Kotov, A. G., et al., (1991) 
b) Phenyl carboxylic acid 
R1
R2
R3
R4
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Name Source R1 R2 R3 R4 Ref. 
Synergic 
acid 
Ligulate and 
tubular floret 
of M. 
chamomilla 
COOH OCH3 OH OCH3
Reichling, J., et al., 
(1979) 
Vanillic 
acid 
Ligulate and 
tubular floret 
of M. 
chamomilla 
COOH H OH OCH3
Reichling, J., et al., 
(1979) 
Anisic acid M. chamomilla COOH H OCH3 H 
Reichling, J., et al., 
(1979) 
Caffeic acid M. chamomilla
 
CH2 CH2COOH
 
OH OH H 
Reichling, J., et al., 
(1979) 
Table 3. Coumarines and other polyphenolic compounds isolated from genus Matricaria 
2.4 Miscellaneous substances 
Chamomile contains up to 10% mucilage polysaccharides (Alternative Medicine Review 
(2008)).The main chain of the polysaccharide consists of -1-> 4 connected D-galacturone 
acids (Carle, R. and Isaac, O.,(1985)). In addition to xylose, arabinose, galactose, glucose, 
rhamnnose (Janecke, H., Weiser, W. (1964))( Janecke, H., Weiser, W.(1965)). 
Recently, three polysaccharides were isolated and showed remarkable antiphlogistic activity 
against mouse ear edema induced by crotone oil (Füller, E., (1992)) as fructane (74.3% 
fructose and 3.4% glucose, similar to inulin), rhamnogalacturonane (28% uronic acid, 3.2% 
protein, similar to pectin), and arabino-3, 6-galactane glycoproteins. 
- Chamomile contains up to 0.3% choline ((Alternative Medicine Review (2008)), (Bayer, 
J. et al. (1958)) which is supposed to be participating in the antiphlogistic activity of the 
extract.  
- More than 13 amino acids were detected (Schilcher, H.,(1980)) from the fresh 
chamomilla herb as L-leucine, DL-methionine, DL--alanine, glycine, L-histidine, L-(+)-
lysine, DL- threonine, DL-serine, and L-glutaminic acid. 
- Tannin level is less than 1% (Alternative Medicine Review (2008). 
3. Some reported pharmacological activity of the chemical constituents of 
Matricaria 
Several pharmacological actions have been assigned for German chamomile, based 
primarily on in vitro and animal studies. Such actions include antibacterial, antifungal, anti-
inflammatory, antispasmodic, anti-ulcer, antiviral, carminative, and sedative effects 
(Alternative Medicine Review 2008). It is important to mention that therapeutic effectiveness 
is mainly due to the combined pharmacological and biochemical effects of several 
chamomile constituents (Schilcher, H.,(1987)). 
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3.1 Apoptotic effect against cancerous cell 
- Darra et al. in 2008 showed that ┙-bisabolol is able to rapidly, efficiently and selectively 
induce apoptosis in malignant tumor cells by targeting lipid rafts on cell membranes. 
Thereafter, ┙-bisabolol could interact with Bid protein (one of pro-apoptotic Bcl-2 
family proteins, analyzed either by Surface Plasmon Resonance method or by intrinsic 
fluorescence measurement) recruited in lipid rafts region after ┙-bisabolol treatment, 
which may be involved in the transduction pathway from plasma membranes to 
intracellular compartments including mitochondria. However, toxicity towards normal 
cells or in animals was absent. (Elena Darra, et al., (2008)) 
- In 2007, Farnesol had been demonstrated by Joo et al. to inhibit proliferation and induce 
apoptosis in a number of neoplastic cell lines from different origins (J.H. Joo,et al., 
(2007)) with preferential action in transformed cells versus untransformed cells (Adany, 
Cancer Lett. (2000)) and (Srivastava JK, Gupta S. (2007))  
- Other preliminary study by Srivastava et al. in 2007 recorded that in vitro exposure to 
chamomile results in differential apoptosis in cancerous cells but not in normal cells at 
similar doses; apigenin and apigenin glycosides appear to be the key components 
responsible for these effects, (Deendayal patel et al. (2007)) 
- Moreover, Patel et al in 2007 identified many mechanisms of action for apigenin-
mediated cancer prevention and therapy, including estrogenic/anti-estrogenic activity, 
anti-proliferative activity, induction of cell-cycle arrest and apoptosis, prevention of 
oxidation, induction of detoxification enzymes, regulation of the host immune system, 
and changes in cellular signaling. This suggests that apigenin possesses enormous 
potential for development as a promising cancer chemopreventive agent in the near 
future for breast, cervical, colon, lung, prostate, ovarian, skin, endometrial, thyroid, and 
gastric, hepatocellular, and adrenocortical cancers as well as leukemia. Pre-clinical 
studies of various animal models of cancer that closely simulate human cancers are still 
needed (Barton, H. 1959). 
3.2 Sedative and anxiolytic effect 
- Shinomiya et al. (Kazuaki S. et al., (2005)) investigated the hypnotic activities of 
chamomile and passiflora extracts using sleep-disturbed model rats. A significant 
decrease in sleep latency was observed with chamomile extract at a dose of 300 mg/kg. 
His findings strongly suggested that chamomile is a herbal product possessed both 
hypnotic and anxiolytic activity in animals.  
- (Avallone R.,et al., (2000) showed that apigenin, a flavonoid isolated from Matricaria 
chamomilla, significantly reduced the locomotor activity in the open field test of rats. 
- (Viola H., et al.,(1995) , in a study about intraperitoneal administration of chamomile 
extract in mice, concluded that apigenin functions as a ligand for benzodiazepine 
receptors, resulting in anxiolytic and mild sedative effects, but no muscle relaxant or 
anticonvulsant effects. He also reported that apigenin extracted from chamomile 
flowers inhibited [3H]-flunitrazepam binding in the bovine cerebral cortex. 
- Gould L., et al.,(1973) reported that hospitalized patients were given a strong chamomile 
tea, and ten of the twelve patients immediately fell into a deep sleep lasting 90 minutes. 
- Della Loggia, R., et al.,(1981)) also demonstrated that chamomile extract caused a 
significant prolongation of sleeping time induced by barbiturates in mice.  
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3.3 Antispasmodic effect 
Both flavonoids and essential oil contribute to the musculotropic antispasmodic effect of 
chamomile. Apigenin, alpha-bisabolol, and the cis-spiroethers appear to provide the most 
significant antispasmodic effects. (Alternative Medicine Review (2008). 
- Maschi et al. in 2008 reported the spasmolytic activity of chamomile was through 
inhibition of cAMP-PDE for the first time. Human platelet cAMP-PDE and recombinant 
PDE5A1 were assayed in the presence of chamomile infusions. Chamomile inhibited 
cAMP-PDE activity (IC50) 17.9-40.5 μg/mL), while cGMP-PDE5 was less affected (-15% 
at 50 μg/mL). Among the individual compounds tested, flavonoids showed an 
inhibitory effect (IC50) 1.3-14.9 μM), contributing to around 39% of the infusion 
inhibition.  
- Carle, R., Gomaa, K. in 1992 demonstrated that the chamomile oil itself, (-)-┙- bisabolol, 
the bisabolol oxides A and B, and the enyne dicycloethers have a papaverine-like 
musculotropic spasmolytic activity. In addition, the coumarin derivates umbelliferone 
and herniarin are also antispasmodically active,(Acheterrath-Tuckermann,et al., 1980) 
- In Tests that was performed using rat or rabbit duodenum, where the contractions were 
induced by barium chloride, acetyl choline, and histamine (Hava M., Janku J. (1957), 
(Janku, J. (1981), apigenin inhibits the contractions of smooth muscle and those of 
seminal vesicle of cavy and of rabbit uterus. 10 mg of apigenin were equieffective to 
about 1 mg of papaverine as for musculotropic effect. (Della Loggia, R. 1985) 
- Other flavonoids contribute to the smooth muscle relaxation but to lesser degree. They 
can be classified in descending activity as follows: apigenin, quercetin, luteolin, 
kaempferol, luteolin-7-glucoside, and apigenin-7-glucoside. (Hörhammer, L.,et al., 
(1963) 
3.4 Antimicrobial effect 
Preliminary in vitro studies on the antimicrobial activity of chamomile have yielded 
promising results. 
- Annuk H,et al., in 1999 proved that chamomile extract at concentration 2.5 mg/ml 
killed trichomonads effectively. It also blocked aggregation of various strains of 
Escherichia coli.  
- Shikov, A., et al., in 1999 demonstrated that chamomile oil extract inhibited the 
production of urease at H. pylori. It was suggested that the mechanism of therapeutic 
action of chamomile oil is based on inhibition of colony activity of H. pylori and an 
inhibiting effect on adhesion of this microorganism of phospholipid — lecithin. 
- Turi M. et al. in 1997 showed that chamomile extract inhibited the growth of poliovirus 
and herpes virus while chamomile esters and lactones demonstrated activity against 
Mycobacterium tuberculosis and Mycobacterium avium. 
- Berry M. in 1995 showed that chamomile oil, at a concentration of 25 mg/mL, 
demonstrated antibacterial activity against such Gram-positive bacteria as Bacillus 
subtilis, Staphylococcus aureus, Streptococcus mutans, and Streptococcus salivarius, as well as 
some fungicidal activity against Candida albicans 
- The strongest antibacterial activity was recorded for ┙- bisabolol. It is active in low 
concentrations against Staphylococcus aureus, Bacillus subtilis, Escherichia coli, 
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Streptococcus faecalis, and Pseudomonas aeruginosa and inhibits the growth of strains of 
Bacterium phlei that were resistant against standard anti-infectives (Szabo-Szalontai, M., 
et al., (1976) and (Szalontai, M.,et al., (1975). Bisabolol, together with enyne 
dicycloethers, also showed fungistatic activity against Candida albicans, Trichophytone 
menthagrophytes, and Trichophytone rubrum at a concentration of 100µg/ml. 
Chamazulene also had this fungistatic activity, but at higher concentrations 
(Szalontai.,M., Verzar-petri, G., Florian, E. (1977). 
3.5 Anti inflammatory effect 
- Recent study in 2009 by Srivastava et al. done on aqueous extract of chamomile flowers 
growing in Egypt, where LPS-activated RAW 264.7 macrophages were used as in vitro 
model, Chamomile treatment inhibited the release of LPS-induced PGE2 in RAW 264.7 
macrophages. This effect was found to be due to inhibition of COX-2 enzyme activity by 
chamomile. In addition, chamomile extract caused reduction in LPS-induced COX-2 
mRNA and protein expression, without affecting COX-1 expression. This suggested 
that mechanism of action of chamomile on the inhibition of PGE2 production was due 
to the suppression of the COX-2 gene expression and direct inhibition of COX-2 enzyme 
activity which is similar to non-steroidal anti inflammatory drugs.  
- (-)-┙- bisabolol was capable of inhibiting both 5-lipoxygenas and cyclooxygenase 
(Szelenyi J., Isaac, O., Thiemer, K., (1979)). It has antipyretic activity against yeast-
induced pyrexia of the rat (Büchi, O. (1959)). Other experiments showed that (-)-┙- 
bisabolol was capable of inhibiting the formation of ulcers induced by indomethacin, 
stress, or alcohol (Szelenyi J., Isaac, O., Thiemer, K., (1979)) 
- Regarding azulenes, their anti inflammatory effect was proven (Zierz, P., Kiessling, W 
(1953), (Zierz, P., et al. (1957) through inhibition of histamine liberation, inhibition of 5-
hydroxytryptamine liberation, anti-hyaluronidase effect, and a decrease of the capillary 
activity ( Uda, T.(1960). This is besides to the activation of the ACTH production (Kato, 
et al. (1959). 
- Chamazulene was identified as the antiphlogistic principle of chamomile oil in a test 
system of chemosis caused by mustard oil in rabbit and cavy eye (Heubner, et al. (1933) 
and Pommer (1942)). It was proved by Ammon et al. in 1996 to inhibit 5-lipoxygenase.  
- Antiphlogistic activity of flavonoids was proved much later (Baumann, J., et al., (1980)), 
(Carle, R., Gomaa, K. (1992), (Della loggia, R. (1985)), Della loggia, R., et al., (1984)), 
(Della loggia R., et al., (1986), Wurm, G., (1982). Apigenin even exceeded the activity of 
indomethacin and phenylbutazone. The experiments further showed that apigenin had 
both a positive influence on the vascular phase of the inflammation (e.g., edema) and on 
the cellular phase (e.g., the migration of leucocytes). Antiphlogistic activity of 
flavonoids decreased in the following order: Apigenin > luteolin > quercetin > 
myricetin > apigenin-7-glucoside > rutin. 
3.6 Anti ulcerative effect 
Torrado S, et al., in 1995 reported that significant protective effect against gastric toxicity of 
200 mg/kg acetylsalicylic acid where achieved after oral administration of chamomile oil to 
rats at doses ranging from 0.8-80 mg/kg bisabolol. Moreover, in vitro studies revealed that 
alpha-bisabolol inhibited gastric ulcer formation induced by indomethacin, ethanol, or 
stress, Szelneyi I, Isaac O., thiemer K. (1979) 
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3.7 Other Pharmacological actions 
3.7.1 Inhibition of Aflatoxin G1 production 
Yoshinari et al. in 2008 showed that the spiroethers of German chamomile inhibited 
production of aflatoxin G1 AFG1 by Aspergillus parasiticus with inhibitory concentration 50% 
(IC50) values of 2.8 and 20.8 mM respectively. This is through inhibiton of cytochrome P450 
monooxygenase CYPA and without inhibiting fungal growth. In addition, it also inhibited 
production of 3-acetyldeoxynivalenol 3-ADON by Fusarium graminearum by inhibiting TRI4. 
The inhibitory activity of the (E)-spiroether isomer was much stronger than that of the (Z)-
spiroether in both cases. Inhibition of TRI4 by the spiroethers showed that TRI4 may be a 
good target for inhibiting biosynthesis of trichothecene mycotoxins. 
3.7.2 Protective effect on diabetic complications 
- Kato et al. in 2008 investigated the effects of chamomile hot water extract and its major 
components on the prevention of hyperglycemia and the protection or improvement of 
diabetic complications in diabetes mellitus. Results suggested that a suppressive effect 
of chamomile on blood glucose level was independent of the inhibition of intestinal ┙-
glycosidases but depended on the inhibition of hepatic glycogen phosphorylase (GP). 
Furthermore, chamomile extract has good inhibitory potency against aldose reductase 
(ALR2), which plays key roles in the polyol pathway and its activation promotes the 
progress of diabetic complications. Chamomile components, umbelliferone, esculetin, 
luteolin, and quercetin, could inhibit sorbitol accumulation in human erythrocytes. 
Therefore, daily consumption of chamomile tea with meals could be potentially useful 
in the prevention and self-medication of hyperglycemia and diabetic complications. 
ATSUSHI KATO,et al ., (2008) 
3.7.3 Antioxidant effect 
- Lado et al. in 2004 studied the volatile oil of several plants and their main components 
to determine their antioxidant activity. This was done by using the modified method of 
ferric reducing ability of plasma (FRAP). The reducing ability of juniper, yarrow, and 
chamomile (145.107 ± 0.007mmol/kg) was very significant and it was twice as high as 
the average values of the other plants (Lavander, salvia, rosemary, etc). The reducing 
abilities of the components of volatile oils are lower than those of volatile oils; therefore, 
the reducing capacities of volatile oils not only attributed solely to terpenes, but also 
other biologically active compounds may also contribute to ferric reduction and in 
electron scavenging (Cristina Lado, et al.,(2004)).  
3.7.4 Inhibition of morphine dependence 
- Gomaa et al. in 2003 showed that co-administration of M. chamomilla extract containing 
0.3% apigenin with morphine not only inhibited dependence to morphine but also 
prevented the increase in plasma cAMP induced by naloxone-precipitated abstinence. 
Furthermore, naloxone precipitated morphine withdrawal behavior syndrome was 
abolished by acute M. chamomilla treatment before naloxone challenge, indicating that 
M. chamomilla extract has an inhibitory effect on the expression of naloxone-precipitated 
morphine withdrawal syndrome. 
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3.7.5 Tachykinin receptor antagonist 
- Yamamoto et al. in 2002 discovered a novel and potent nonpeptide tachykinin NK1 
receptor antagonist in the extract of dried flowers of Matricaria chamomilla. . It has a unique 
structure of a polyacylated Spermine which was established as N1, N5, N10, N14-tetrakis 
[3-(4-hydroxyphenyl)-2-propenoyl]-1, 5, 10, 14-tetraazatetradecane (tetracoumaroyl 
spermine). The Ki values of 1a, estimated from the inhibitory action on the substance P 
(SP)-induced contraction of the guinea pig ileum and the inhibition of the binding of 
[3H][Sar9, Met(O2)11]SP to human NK1 receptors, were 21.9 nM and 3.3 nM, respectively.  
4. Clinical indications of Matricaria chamomilla 
German chamomile is a well-known and widely used herb in different parts of the world. 
Few well designed, randomized, double-blind; placebo-controlled studies are available to 
fully assess its therapeutic benefit. (Alternative Medicine Review 2008) 
4.1 Gastrointestinal effect 
- De la Motte S, (1997) conducted a prospective, randomized, multicenter, double-blind, 
parallel group trial, where 79 children (ages six months to five years) with acute, non 
complicated diarrhea received either a commercial preparation of apple pectin and 
chamomile extract or placebo for three days, in addition to a typical rehydration and re-
alimentation diet. At the end of three days, significantly more children in the 
pectin/chamomile group (85%) experienced diarrhea alleviation compared to the 
placebo group (58%) (p<0.05). The pectin/chamomile combination experienced a 
significant 5.2-hour shorter duration of symptoms compared to the placebo group. 
Weizman Z. et al. in 1993 in double-blind studies observed the efficacy of a herbal 
decoction consisting of German chamomile, vervain, licorice, fennel, and balm mint on 
68 healthy infants with colic. For seven days the infants (ages 2-8 weeks) received 150 
mL of the herbal preparation or placebo with each colic episode, but no more than three 
times daily. After seven days, 57 percent of the infants receiving the herbal preparation 
experienced colic relief compared to 26 percent in the placebo group (p<0.01).  
- Schmid et al. in 1975 showed that chamomile extract is successfully applied in 
pediatrics due to its carminative and spasmolytic effect with diseases of the 
gastrointestinal tract and the effect as such is said to set in immediately after taking the 
preparation. The internal administration of chamomile tea or preparations from 
chamomile extracts is appropriate in different gastric troubles that can be classed under 
term of “dyspepsia,” as recorded by Weiss in 1987. 
4.2 General anti-inflammatory effect 
- In 1999 Schilcher demonstrated that chamomile extract therapy is advisable in 
pediatrics for sensitive skin care of babies, treatment of an inflamed skin or skin defects 
(as dermatitis ammoniacalis, scald and burn areas and exfoliative dermatitis), and for 
the treatment of inflammations of the nose and the paranasal sinus by application of a 
chamomile bath and inhalation. 
- Nasemann et al. in 1991 reported about the antiphlogistic effect of Kamillosan® 
ointment in comparison with a nonsteroidal ointment in case of episiotomies, with 
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colpitis senilis, and about the improvement of the healing of wounds after surgical 
operations carried out by laser in gynecology after taking a chamomile (hip) bath.  
- Carle et al. in 1987, and according to reports of various gynecological hospitals, showed 
that chamomile extract is a suitable remedy for the treatment of bartholinitis, vulvitis, 
and mastitis and in rare cases secondarily healing episiotomies.  
4.3 Dermatologyical effect 
- Stechele in 1991 and according to a pediatrician’s open report showed that very good 
results could be achieved by using chamomile ointment for the treatment of napkin 
dermatitis.  
- Aertgeerts P et al. in 1985, in an open, bilateral comparative trial, 161 patients with 
eczema on their hands, forearms, and lower legs initially treated with 0.1-percent 
diflucortolone valerate received one of four treatments: chamomile cream (Kamillosan), 
0.25-percent hydrocortisone, 0.75-percent fluocortin butyl ester (a glucocorticoid), or 
5.0-percent bufexamac (a nonsteroidal anti-inflammatory). After 3-4 weeks, the 
chamomile cream was found to be as effective as hydrocortisone and demonstrated 
superior activity to bufexamac and fluocortin butyl ester. 
- As for Born in 1991, chamomile extract was applied for the irrigation of undermined 
margins of a wound, pouches, sinus tracts, and hip baths, correspondingly diluted or in 
concentrated form for swabbing inflammatory lesions of the mucosa.  
- Contzen in 1975 proved that the chamomile bath can be used successfully with the local 
treatment of deep second-degree burns. Apart from an accelerated cleansing process of 
a wound a significant improvement of the granulation is also observed. Deep necroses 
are excised; superficial ones heal without proteolytic ferments.  
- Glowania HJ et al. in 1987and through a double-blind trial examined the therapeutic 
efficacy of a topical chamomile extract on 14 patients with weeping dermabrasions from 
tattoo applications. Those using chamomile noted a statistically significant decrease in 
the weeping wound area and increased drying compared to the placebo group.  
4.4 Sleep enhancement 
In an open case study to examine the cardiac effects of two cups of chamomile tea on 
patients undergoing cardiac catheterization, Gould L. et al. observed that 10 of 12 patients in 
the study achieved deep sleep within 10 minutes of drinking the tea, Gould L, et al. (1973). 
The patients had a small but significant increase in mean brachial artery pressure. No other 
significant hemodynamic changes were observed. 
4.5 Radiation therapy 
- Fidler P. et al. in 1996 conducted a randomized, double-blind study with 164 cancer 
patients taking 5-fluorouracil (5-FU) chemotherapy. The patients rinsed three times 
daily with either a chamomile mouthwash or placebo. After 14 days, no difference was 
observed between the two groups in the incidence of stomatitis induced by 5-FU.  
- Carl W. et al. 1991 examined the effect of 15 drops of Kamillosan Liquidum, a German 
chamomile mouthwash preparation, in 100 mL of water taken three times daily, for 
radiation and/or chemotherapy-induced mucositis (characterized by inflammation and 
ulceration of the gastrointestinal tract including the mouth). Cancer patients (n=98) 
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were divided into two groups. One group of 66 patients (20 undergoing radiation 
therapies, 46 undergoing chemotherapy) participated in prophylactic oral care with the 
mouthwash. The remaining 32 patients underwent chemotherapy and were treated 
therapeutically after mucositis had developed. Of the 20 patients undergoing radiation, 
only one developed high-grade (grade 3) mucositis in the final week of treatment, 65 
percent developed intermediate grade mucositis, and 30 percent developed low-grade 
mucositis. Of the 46 patients concurrently receiving chemotherapy and the mouthwash, 
36 remained free of any clinically significant mucositis. Of the 32 patients with existing 
mucositis, all noted immediate relief from mouth discomfort, and within seven days 
almost all patients had no clinical sign of mucositis.  
- Maiche AG et al. in 1991 carried out a double-blind, randomized, placebo-controlled 
study, where 48 women receiving radiation therapy for breast cancer were treated 
topically with either chamomile cream or placebo (almond oil) to protect the radiation-
treated area. While there were no significant differences between the two groups in 
objective scores of skin irritation, the patients preferred the chamomile containing 
cream to the placebo for its rapid absorption and stainlessness.  
- According to Bulmenberg, E.-W., Hoefer-Janker, H. (1972), the reactions of mucosa of the 
rectum resulting from a highly dosed radiation therapy, frequently felt to be unendurable; 
can also be treated successfully with chamomile extract. For that purpose enema is given 
three times a week; besides antiphlogistic properties, this also has a mild cleaning effect  
4.6 Other uses 
- According to Hinz in 1995, a standardized ethanolic-aqueous chamomile flower extract 
is suitable for the adjuvant therapy of Angina lacunaris and for the symptomatic 
treatment of herpangina often occurring in (early) childhood. In addition has a pain-
alleviating effect in cases of inflammatory and painful esophageal diseases. 
5. Photograph of the two matricaria specie 
 
Fig. 1. Photograph of Matricaria aurea  
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Fig. 2. Photograph of Matricaria chamomilla.  
(10-40cm in height, with erect, branching stems .the capitulum (to 1.5cm in diameter) 
comprises 12-20 white ligulate florets surrounding a conical hollow receptacle on which 
numerous yellow tubular (disk) florets are inserted (Bruneton J. (1995)) 
6. Conclusions and recommendations 
A lot of studies have been conducted on Matricaria chamomilla all over the world where 
many important biologically active compounds have been separated and identified. 
However, very few studies are available for Matricaria aurea world wide. Nowadays, 
researches are focusing on exploring the pharmacological profile of compounds from 
natural origin, where promising results aroused. Challenges remain in finding ways to 
benefit from these biologically important compounds in treating human health problems. 
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